| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.05 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.05 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.067 | 0.06 |